A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...

Chart IV reveals a strong link between business reforms and industrial activity, reinforcing the need for deregulation, enterprise-friendly policies, and streamlined industrial reforms.

Before we get to our kratom dosage chart, let’s briefly examine one of the most exclusive kratom strains, Dragon kratom. This kratom strain is naturally growing only on the lush green island of ...

Data from the off-treatment period between the Study 201 (Phase 2) core study and LTE showed that discontinuation of treatment is associated with reaccumulation of amyloid PET and plasma and CSF ...

The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the monthly intravenous (IV) maintenance ... 4 weeks 10mg/kg dosing regimen following ...

LEQEMBI®) intravenous (IV) maintenance dosing. LEQEMBI is indicated for the treatment of Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) or mild dementia stage of disease ...

(MENAFN- JCN NewsWire) FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the treatment of Early Alzheimer's Disease Once every four weeks maintenance dosing may be easier for ...

intravenous (IV) maintenance dosing. LEQEMBI is indicated for the treatment of Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) or mild dementia stage of disease (collectively ...

Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA ...